PMP22 and central nervous system disorder: Proteins linked to cancers (e.g., the tumour suppressor, CDKN2A), CNS disorders (e.g., the myelin constituent, PMP22), and developmental disorders (e.g., skeleton and tooth development protein, SLC10A7) were represented at fCEAA and fEAA extremes.